AzTrials
AzTrials

MobilityGAMERSNCT06797895

Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units

A study testing VR assisted mobility in people with Mobility and ICU, run by Duke University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this study is to explore if Virtual Reality helps patients in the cardiothoracic ICU move more and feel better. Participants will be asked to answer a survey about anxiety, depression, and loneliness. The study team will teach participants how to use the VR device and how to play the game. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mobility, ICU, Heart Surgery
What is being tested?
VR assisted mobility
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
4 Dec 2024to Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult
  • English speaking
  • 3+ days ICU admission with limited mobility

Who cannot join

  • Pregnancy
  • Blind/severe visual impairment
  • History of seizures
  • Intubation/sedation
  • Special enteric contact isolation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University Hospital

    Durham, North Carolina, 27710

Other trials in United States

About this study

The goal of this study is to explore if Virtual Reality helps patients in the cardiothoracic ICU move more and feel better. Participants will be asked to answer a survey about anxiety, depression, and loneliness. The study team will teach participants how to use the VR device and how to play the game. Participants will play the game at least once per day, but can play as much as they want. Study activities include nurse facilitated patient use of VR applications that involve upper body movement (e.g., using arms and hands to dance or hit objects in a virtual reality environment).

Read the detailed description

Patients who survive critical illness and prolonged intensive care unit (ICU) stays are at risk for debilitating physical (deconditioning, skin injury, and infection), and mental health impairment (depression, anxiety and PTSD). Early mobility improves these deleterious outcomes but is challenging to implement in patients on prolonged bedrest. The purpose of this study is to compare a nurse-led implementation of a Virtual Reality (VR) experience in the Cardio-Thoracic Intensive Care Unit (CT-ICU) to standard of care to improve mobility for patients on prolonged bedrest. The investigators hypothesize that nurse-led implementation of VR experiences in the CT-ICU, in combination with engineering-led patient-centered customization of the VR applications, will improve both the physical and psychological function of ICU patients on prolonged bedrest.

Being tested
VR assisted mobility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR assisted mobilityBehavioural

    Commercially-based VR experience used to help move upper extremities to music, similar to dancing or Tai-Chi.

Study groups in NCT06797895
Study groupRoleWhat they receive
Virtual Reality (VR) interventionOtherCohort for observing the effects of the VR intervention on ICU mobility.
Receives: Behavioral: VR assisted mobility

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility as measured by nursing time required

    For each participant, the total nursing time spent (in minutes) setting up and delivering the intervention will be recorded.

    Measured: up to 6 months

Secondary outcomes (10)
  1. Usability as measured by patient-reported ease of playing the game

    Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess ease of playing the game.

    Measured: up to 6 months

  2. Usability as measured by patient-reported ease of hand controller use

    Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess ease of hand controller use.

    Measured: up to 6 months

  3. Usability as measured by patient-reported wearability of headset

    Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess wearability of headset.

    Measured: up to 6 months

  4. Usability as measured by patient-reported comfort of headset

    Usability: Using a 5-point Likert scale (0- very difficult to 5- very easy; higher is better outcome), participants will be surveyed after the intervention period to assess comfort of headset.

    Measured: up to 6 months

  5. Number of participants who find the intervention acceptable

    Acceptability: Participants will be asked if they would recommend this game to a friend or loved one, yes or no.

    Measured: up to 6 months

  6. Change in mobility activity frequency

    To determine if a VR intervention increases mobility for patients on prolonged bedrest, the frequency of VR sessions is recorded. Frequency will be reported as counts.

    Measured: Baseline, 6 months

  7. Change in mobility activity time

    To determine if a VR intervention increases mobility for patients on prolonged bedrest, the duration of each VR session is recorded. Activity will be reported as total minutes.

    Measured: Baseline, 6 months

  8. Change in Hospital Anxiety and Depression Scale (HADS) - anxiety

    The Hospital Anxiety and Depression Scale (HADS) is a self-report scale used to measure the severity of depression and anxiety in patients with comorbid medical conditions. The total score for anxiety ranges from 0 to 21, where a higher score indicates greater anxiety.

    Measured: Baseline to day 10 or ICU transfer, whichever comes first

  9. Change in Hospital Anxiety and Depression Scale (HADS) - depression

    The Hospital Anxiety and Depression Scale (HADS) is a self-report scale used to measure the severity of depression and anxiety in patients with comorbid medical conditions. The total score for depression ranges from 0 to 21, where a lower score indicates greater depression.

    Measured: Baseline to day 10 or ICU transfer, whichever comes first

  10. Change in UCLA 3-item Loneliness Scale

    This scale comprises 3 questions that measure three dimensions of loneliness: relational connectedness, social connectedness and self-perceived isolation. The total score ranges from 0 to 9, where a higher score indicates greater loneliness.

    Measured: Baseline to day 10 or ICU transfer, whichever comes first

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2025
  2. Study start4 Dec 2024
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06797895
Sponsor's protocol ID
PRO00116448
Acronym
GAMERS
Status last verified
Feb 2026
First submitted
9 Dec 2024
Last updated
18 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR assisted mobility in people with Mobility and ICU, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility as measured by nursing time required (time frame: up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in